| 注册
首页|期刊导航|中国临床药理学与治疗学|人参皂苷Rg1对人胃癌BGC-823的抑制作用研究

人参皂苷Rg1对人胃癌BGC-823的抑制作用研究

赵保胜 刘洋 徐暾海

中国临床药理学与治疗学2011,Vol.16Issue(4):361-365,5.
中国临床药理学与治疗学2011,Vol.16Issue(4):361-365,5.

人参皂苷Rg1对人胃癌BGC-823的抑制作用研究

Inhibitory effect of ginsenoside Rgl on BGC-823 human gastric cancer cell line

赵保胜 1刘洋 2徐暾海2

作者信息

  • 1. 北京中医药大学科研实验中心,北京100029
  • 2. 北京中医药大学中药学院,北京100102
  • 折叠

摘要

Abstract

AIM: To observe the influences of Ginsenoside Rgl on the activity, proliferation,the expression of Bax-2 and caspase-3 and morphology of BGC-823 gastric cancer cell line, and investigate its pharmacological mechanisms.METHODS: Cells which were stayed in logarithmic growth were used for the experiments, the cells were interfered with different concentration of Ginsenoside Rgl, the methods of growth curve, M'IT assay, protein content assay Realtime PCR and morphological observation were used to investigate the effects of Ginsenoside Rgl on BGC-823 cells. RESULTS: Ginsenoside Rgl had potent inhibitory effect on BGC-823 cell line in a dose-dependent and time-dependent manner. Ginsenoside Rgl had significant cytotoxic effect to BGC-823 cells, and its half maximal inhibitory concentration (IC50) is 29.56 mg/L. Ginsenoside Rgl decreased the amount of protein in BGC-823 cells, improved the expression of Bax-2、caspase-3, and caused the shrinkage of cells, the cytoplasm decreased, and the color was salmon pink; the chromatin condensed and the color was intense violet; the cellular nucleuses were condensed or broken into round granules. CONCLUSION: Ginsenoside Rgl obviously inhibited the cell proliferation, decreased its activity, showed conspicuous anti-tumor effect on BGC-823 cells. The anti-tumor effect may be related to the inhibition effect to tumor cell protein synthesis, and promote the apoptosis of BGC-823 cells.

关键词

人参皂苷Rg1/胃癌/BGC-823细胞株/细胞增殖/细胞凋亡

Key words

Ginsenoside Rgl/ Gastric cancer/ BGC-823/ Cell proliferation/ Apoptosis

分类

医药卫生

引用本文复制引用

赵保胜,刘洋,徐暾海..人参皂苷Rg1对人胃癌BGC-823的抑制作用研究[J].中国临床药理学与治疗学,2011,16(4):361-365,5.

基金项目

教育部科学技术研究重点项目(108132) (108132)

北京市教育委员会共建项目 ()

中国临床药理学与治疗学

OACSCDCSTPCD

1009-2501

访问量0
|
下载量0
段落导航相关论文